Roumiguie Mathieu

Chirurgie urologique

Hôpital Rangueil
Toulouse, France

547 Activités

1.5 K Followers

Scientifique

Digital

Production scientifique

Activités par an

Expertise

Sujets de recherche

Tumeurs de la prostate Tumeurs de la vessie urinaire Carcinomes Tumeurs du rein Carcinome transitionnel Non-Muscle Invasive Bladder Neoplasms Complications postopératoires Récidive tumorale locale Invasion tumorale

Collaborateurs

Soulie Michel

Hôpital Rangueil, Toulouse, France

Beauval Jean-Baptiste

Cabinet libéral, Quint-Fonsegrives, France

Game Xavier

Hôpital Rangueil, Toulouse, France

Doumerc Nicolas

Hôpital Rangueil, Toulouse, France

Industries

Janssen

15 collaboration(s)

Dernière en 2023

Astellas

14 collaboration(s)

Dernière en 2023

Ipsen

12 collaboration(s)

Dernière en 2023

AstraZeneca

9 collaboration(s)

Dernière en 2023

Dernières activités

Study of Pembrolizumab (MK-3475) and Pembrolizumab With Other Investigational Agents in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057): A Phase II Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) and Pembrolizumab in Combination With Other Investigational Agents in Subjects With High Risk Non-muscle-Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy

Essai Clinique (Merck & Co.) 20 mars 2024

SUGAR: SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer

Essai Clinique (Bayer) 29 janvier 2024

Correction to: Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions.

Prostate cancer and prostatic diseases 10 novembre 2023

Étude comparative des coûts de la transplantation rénale robot-assistée et par voie ouverte : analyse monocentrique en France